SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-045417
Filing Date
2019-08-13
Accepted
2019-08-13 07:05:47
Documents
3
Period of Report
2019-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-12910_38k.htm 8-K 30321
2 EX-99.1 a19-12910_3ex99d1.htm EX-99.1 124101
3 GRAPHIC g129103mm01i001.jpg GRAPHIC 3109
  Complete submission text file 0001104659-19-045417.txt   160029
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 191018220
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1